Kotak Healthcare Fund - IDCW - Regular Plan

  • Previous Nav

  • Net Change on 23-03-2026

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview IDCW | Regular Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

The investment objective of the scheme is to seek to generate long term capital appreciation throughinvesting in equity and equity related securities of companies benefitting directly or indirectly Pharma, Healthcare, and allied sectors.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
NIFTY 50 - TRI N/A N/A N/A N/A N/A N/A
Nifty Healthcare Index - TRI N/A N/A N/A N/A N/A N/A

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
NIPPON INDIA PHARMA FUND - IDCW Option Jun 05, 2004 2.63 23.09 15.57 1.81 8,306.35
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - IDCW Option Jul 13, 2018 2.47 27.01 17.35 1.86 6,801.16
SBI Healthcare Opportunities Fund - Regular Plan - Income Distribution cum Capital Withdrawal Option (IDCW) Jul 03, 1999 1.61 24.83 17.47 1.93 4,076.67
DSP Healthcare Fund - Regular Plan - IDCW Nov 30, 2018 -2.90 20.93 14.44 1.94 3,033.42
Mirae Asset Healthcare Fund Regular IDCW Jul 02, 2018 5.33 24.81 16.10 1.93 2,843.74

Fund Holdings as on 28-February-2026

  • SUN PHARMACEUTICAL INDUSTRIES LTD.

  • Max Healthcare Institute Ltd.

  • JB Chemicals & Pharmaceuticals Ltd.

  • Divis Laboratories Ltd.

  • Fortis Healthcare India Ltd

  • Lupin Ltd.

  • Cipla Ltd.

  • Ami Organics Ltd

  • PARK MEDI WORLD LIMITED (PARK HOSPITAL)

  • Apollo Hospitals Enterprise Ltd.

  • KRISHNA INSTITUTE OF MEDICAL SCIENCES LTD.

  • SAI LIFE SCIENCES LIMITED

  • Ajanta Pharma Ltd.

  • Gland Pharma Limited

  • Alkem Laboratories Ltd.

  • Aurobindo Pharma Ltd.

  • JUBILANT PHARMOVA LIMITED

  • ANTHEM BIOSCIENCES LTD

  • Glenmark Pharmaceuticals Ltd

  • CORONA REMEDIES LIMITED

  • Dr.Reddy's Laboratories Ltd.

  • MANKIND PHARMA LTD

  • Marksans Pharma Ltd

  • RUBICON RESEARCH LIMITED

  • Zydus Lifesciences Ltd.

  • EMCURE PHARMACEUTICALS LIMITED

  • Triparty Repo

  • YATHARTH HOSPITAL AND TRAUMA CARE SERVICES LTD

  • ORCHID PHARMA LIMITED

  • LAXMI DENTAL LIMITED

  • RAINBOW CHILDRENS MEDICARE LTD

  • INNOVA CAPTABS LTD

  • MEDI ASSIST HEALTHCARE SERVICES LIMITED

  • Net Current Assets/(Liabilities)

View More
  • Pharmaceuticals & Drugs

  • Hospital & Healthcare Services

  • Miscellaneous

  • Medical Equipment/Supplies/Accessories

  • Business Support

View More

Fund Manager

  • Cash

  • Equity

View More

About Kotak Healthcare Fund

Scheme Analysis

Kotak Healthcare Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to Kotak Mahindra Mutual Fund. It was launched on 11-Dec-2023 and currently has an AUM of ₹485.24 crore. Kotak Healthcare Fund is benchmarked against NIFTY 50 - TRI as primary index and Nifty Healthcare Index - TRI as secondary index.

The NAV of Kotak Healthcare Fund ended down ₹-0.32(-2.41%)yesterday to ₹13.018.

Among its top 3 holdings the fund has exposure to SUN PHARMACEUTICAL INDUSTRIES LTD., and

The Kotak Healthcare Fund is managed by Abhishek Bisen and Shibani Kurian.

Fund House Contact

27 BKC, C-27, G Block, Bandra Kurla Complex, Bandra (E), Mumbai - 400 051

+91 (22) 66384400
mutual@kotak.com
+91 (22) 66384455